Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rep turnover in India "as high as 30-40%" as expanding firms compete with other sectors

This article was originally published in Scrip

Executive Summary

The Indian pharmaceutical industry, seen as a hotbed of future growth and with several success stories to its credit, appears to have got it right in most areas of operation. But there are worrying signs that it may not be up to scratch when it comes to people issues, with overall employee attrition rates in the Indian industry well above global rates.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC014393

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel